Naelapää K - Search Results

1

Near infrared analysis of pharmaceutical powders with empirical target distribution optimization (ETDO).

Pedersen T, Rantanen J, Naelapää K, Skibsted E. Pedersen T, et al. Among authors: naelapaa k. J Pharm Biomed Anal. 2020 Mar 20;181:113059. doi: 10.1016/j.jpba.2019.113059. Epub 2019 Dec 20. J Pharm Biomed Anal. 2020. PMID: 31978645

2

Increasing process understanding by analyzing complex interactions in experimental data.

Naelapää K, Allesø M, Kristensen HG, Bro R, Rantanen J, Bertelsen P. Naelapää K, et al. J Pharm Sci. 2009 May;98(5):1852-61. doi: 10.1002/jps.21565. J Pharm Sci. 2009. PMID: 18781630

3

Building quality into a coating process.

Naelapää K, Veski P, Kristensen HG, Rantanen J, Bertelsen P. Naelapää K, et al. Pharm Dev Technol. 2010 Jan-Feb;15(1):35-45. doi: 10.3109/10837450902882377. Pharm Dev Technol. 2010. PMID: 19694502

4

X-ray powder diffractometry in combination with principal component analysis--a tool for monitoring solid state changes.

Kogermann K, Veski P, Rantanen J, Naelapää K. Kogermann K, et al. Among authors: naelapaa k. Eur J Pharm Sci. 2011 Jul 17;43(4):278-89. doi: 10.1016/j.ejps.2011.05.001. Epub 2011 May 7. Eur J Pharm Sci. 2011. PMID: 21575718

5

Polymorphic form of piroxicam influences the performance of amorphous material prepared by ball-milling.

Naelapää K, Boetker JP, Veski P, Rantanen J, Rades T, Kogermann K. Naelapää K, et al. Int J Pharm. 2012 Jun 15;429(1-2):69-77. doi: 10.1016/j.ijpharm.2012.03.008. Epub 2012 Mar 14. Int J Pharm. 2012. PMID: 22433471

6

Complementing high-throughput X-ray powder diffraction data with quantum-chemical calculations: Application to piroxicam form III.

Naelapää K, van de Streek J, Rantanen J, Bond AD. Naelapää K, et al. J Pharm Sci. 2012 Nov;101(11):4214-9. doi: 10.1002/jps.23287. Epub 2012 Aug 8. J Pharm Sci. 2012. PMID: 22886472

7

Real-time dissolution behavior of furosemide in biorelevant media as determined by UV imaging.

Gordon S, Naelapää K, Rantanen J, Selen A, Müllertz A, Østergaard J. Gordon S, et al. Among authors: naelapaa k. Pharm Dev Technol. 2013 Nov-Dec;18(6):1407-16. doi: 10.3109/10837450.2012.737808. Epub 2012 Nov 9. Pharm Dev Technol. 2013. PMID: 23136844

8

Dissolution testing of amorphous solid dispersions.

Kogermann K, Penkina A, Predbannikova K, Jeeger K, Veski P, Rantanen J, Naelapää K. Kogermann K, et al. Among authors: naelapaa k. Int J Pharm. 2013 Feb 28;444(1-2):40-6. doi: 10.1016/j.ijpharm.2013.01.042. Epub 2013 Jan 28. Int J Pharm. 2013. PMID: 23370435

9

Evaluating the effect of coating equipment on tablet film quality using terahertz pulsed imaging.

Haaser M, Naelapää K, Gordon KC, Pepper M, Rantanen J, Strachan CJ, Taday PF, Zeitler JA, Rades T. Haaser M, et al. Among authors: naelapaa k. Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):1095-102. doi: 10.1016/j.ejpb.2013.03.019. Epub 2013 Apr 4. Eur J Pharm Biopharm. 2013. PMID: 23563103

10

Simultaneous UV imaging and raman spectroscopy for the measurement of solvent-mediated phase transformations during dissolution testing.

Østergaard J, Wu JX, Naelapää K, Boetker JP, Jensen H, Rantanen J. Østergaard J, et al. Among authors: naelapaa k. J Pharm Sci. 2014 Apr;103(4):1149-56. doi: 10.1002/jps.23883. Epub 2014 Feb 4. J Pharm Sci. 2014. PMID: 24496995

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters